Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh

Indian Journal of Gastroenterology

Volumn 33, Issue 5, 2014, Pages 452-457

  Alam, Shahinul ^a   Gupta, Utpal Das ^a   Alam, Mahbubul ^a   Kabir, Jahangir ^a   Chowdhury, Ziaur Rahman ^a   Alam, A K M Khorshed ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

BMI; Fatty liver; Metabolic syndrome; NASH

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BANGLADESH; BLOOD PRESSURE; BODY MASS; CHEMOLUMINESCENCE; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NONOBESE NONALCOHOLIC FATTY LIVER DISEASE; WAIST CIRCUMFERENCE; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; OBESITY; PATHOLOGY; SEX;

ADULT; BANGLADESH; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; HUMANS; INSULIN RESISTANCE; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; SEX;

EID: 84908307124     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-014-0488-5     Document Type: Article

References (43)

1. Adams LA, Lindor KD. Nonalcoholic fatty liver disease. Ann Epidemiol. 2007;17:863–5.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1226–31.
3. Clark JM, Brancati FL, Dieh AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57.
4. Amarpurkar DN, Hashimoto E, Lesman LA, Sollano JD, Chan PJ, Goh KL. Asia-pacific working party on nonalcoholic fatty liver disease. How common is NAFLD in the Asia-pacific region and are there local differences? J Gastroenterol Hepatol. 2007;22:788–93.
5. Younossi ZM, Stepanovo M, Fang Y, Younossi Y, Mir H, Shrishard M. Changes in prevalence of the most common causes of chronic liver disease in United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–30.
6. Amarpurkar D, Kumani P, Patel N, et al. Prevalence of nonalcoholic fatty liver disease, population based study. Ann Hepatol. 2007;61:161–3.
7. Fabbini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease biochemical, metabolic and clinical implications. Hepatology. 2010;51:679–89.
8. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–85.
9. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subject with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.
10. Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver disease and significant liver disease. Hepatology. 2010;51:1593–602.
11. Merra F, Bertolani C. Adipokines in liver diseases. Hepatology. 2009;50:957–69.
12. Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 2012;11:478–86.
13. Francazani AL, Valenti L, Buigianesi E, et al. Risk of NASH and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol. 2011;54:1244–49.
14. Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP. Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol. 2007;102:399–408.
15. Madan K, Batra Y, Gupta SD, et al. Nonalcoholic fatty liver disease may not be a severe disease at apresentation among Asian Indians. World J Gastroenterol. 2006;12:3400–5.
16. Belleantini S, Marino M. Epidemiology and natural history of nonalcoholic fatty liver disease. Ann Hepatol. 2009;8 Suppl 1:S4–8.
17. Sing DK, Sakhuja P, Malhotra V, Gondal R, Sarin SK. Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with NASH. Dig Dis Sci. 2007;52:2368–74.
18. Succuro E, Marini MA, Frontini S, et al. Insulin secretion in metabolically healthy but obese individuals. Obesity (Silver Spring). 2008;16:1881–6.
19. Heng D, Ma S, Lee JJ, et al. Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease. Atherosclerosis. 2006;186:367–73.
20. Expert WHO. Consultation. appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.
21. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.
22. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.
23. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462–8.
24. Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48:792–8.
25. Duseja A, Das A, Das R, et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci. 2007;52:2368–74.
26. Bajaj S, Nigam P, Luthra A, et al. A case–control study on insulin resistance, metabolic co-variates and prediction score in non-alcoholic fatty liver disease. Indian J Med Res. 2009;129:285–92.
27. Agarwal AK, Jain V, Singla S, et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India. 2011;59:351–4.
28. Bellentani S, Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–7.
29. Petersen KF, Dufour S, Feng J, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci. 2006;103:18273–27.
30. Kumar R, Rastogi A, Sharma MK, et al. Clinicopathological characteristics and metabolic profile of nonalcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocr Metab. 2013;17:665–71.
31. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–23.
32. Uchil D, Pipalia D, Chawla M, et al. Non-alcoholic fatty liver disease (NAFLD): the hepatic component of metabolic syndrome. J Assoc Physicians India. 2009;57:201–4.
33. Das SK, Balakrishnan V. Role of cytokines in the pathogenesis of non-alcoholic fatty liver disease. Indian J Clin Biochem. 2011;26:202–9.
34. Viswanathan V, Kadiri M, Medipudi S, Kumpatla S. Association of non-alcoholic fatty liver disease with microvascular and macrovascular complications in south Indian diabetic subjects. Int J Diabetes Dev C. 2010;30:208–12.
35. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99–S112.
36. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–50.
37. Kim HJ, Kim HJ, Lee KE, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med. 2004;164:2169–75.
38. Hooper AJ, Adams LA, Burnett JR. Genetic determinants of hepatic steatosis in man. J Lipid Res. 2011;52:593–617.
39. Santoro N, Kursawe R, D’Adamo E, et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology. 2010;52:1281–90.
40. Alam SL, Noor-E-Alam SM, Chowdhury ZR, Alam M, Kabir J. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. World J Hepatol. 2013;5:281–7.
41. Wong VW, Wong GL, Tsang SW, et al. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther. 2009;29:387–96.
42. Neuschwander-Tetri BA, Clark JM, Bass NM, et al. NASH clinical research network. clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology. 2010;52:913–24.
43. Alam S, Ahmad N, Mustafa G, et al. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B. Liver Int. 2011;31:824–30.